Do Lobsters Get Cancer? The Science of Their Resilience

The American lobster can live for many decades, growing and reproducing throughout its entire lifespan. This pattern of indeterminate growth, where an animal does not weaken or slow down with age, presents a biological puzzle. In nearly every other species, advanced age and continuous cell division significantly increase the likelihood of developing malignant tumors. The fact that these long-lived crustaceans rarely succumb to cancer suggests they possess highly effective biological defenses against uncontrolled cell growth. Studying their resilience offers unique insights into the mechanics of longevity and disease suppression.

The Biological Reality: Do Lobsters Get Cancer?

The straightforward answer to whether lobsters get cancer is nuanced: true, metastasizing malignant cancer is extremely rare in lobsters and other decapod crustaceans. Malignant tumors, defined by cells that proliferate uncontrollably and spread to distant tissues, are almost non-existent in the scientific literature for these animals. Reports of abnormal growths are often misdiagnoses or refer to different types of pathology entirely.

Scientists have observed non-malignant growths, called neoplasms, in crustaceans, but these are distinct from the aggressive cancers seen in vertebrates. These abnormal cell clusters are often benign or localized and may be caused by infectious agents or inflammatory responses, not genetic mutations leading to systemic disease. The scarcity of documented cases suggests that the lobster’s unique physiology and cellular mechanisms effectively prevent the formation or spread of true cancer. This low incidence is striking considering their extensive lifespans, which should statistically translate to a higher cancer risk.

The Role of Telomerase in Cellular Immortality

A fascinating aspect of lobster biology is their ability to continually regenerate cells without experiencing senescence, or biological aging. In most animals, including humans, chromosomes are protected by telomeres, repetitive DNA sequences that shorten slightly with every cell division. When telomeres become too short, the cell enters senescence, a natural defense mechanism that halts proliferation to prevent damaged cells from becoming cancerous.

Lobsters bypass this biological clock through the ubiquitous expression of an enzyme called telomerase. This enzyme acts like a repair mechanism, adding new DNA sequences to the ends of telomeres after each division, effectively rebuilding them. High telomerase activity has been detected across all adult lobster organs, unlike in vertebrates where it is limited to germline or stem cells. This constant telomere maintenance grants their cells an almost indefinite capacity to divide, forming the basis of their ageless growth.

This mechanism is a double-edged sword because the indefinite cell division that permits longevity is also a hallmark of human cancer cells, which often activate telomerase to become “immortal.” The fact that lobsters possess this capacity yet remain largely cancer-free underscores the power of their other tumor-suppressing systems. Their ability to manage the risk associated with this cellular immortality is a testament to the effectiveness of their overall biological resilience.

Unique Immune System Response

The second major line of defense against cancer lies in the lobster’s unique immune system, which is fundamentally different from that of mammals. Lobsters possess an innate immune system, a rapid, non-specific response, but they lack the adaptive immune system found in vertebrates. Adaptive immunity involves specialized cells like T-cells and antibodies that “remember” previous invaders, providing long-term protection.

The primary immune cells in lobsters are circulating blood cells known as hemocytes. These hemocytes are responsible for both cellular and humoral (fluid-based) defense mechanisms. When a hemocyte detects an abnormal cell, foreign particle, or potential tumor, it initiates a robust physical response.

This response often involves a process called phagocytosis, where the hemocyte engulfs and destroys the foreign material. For larger threats, such as potential tumor masses, hemocytes will physically surround and isolate the aberrant cells in a process called encapsulation. This physical barrier is often accompanied by melanization, which deposits a dark, melanin-based substance that starves the encapsulated tissue of nutrients and oxygen, thereby controlling or destroying the localized growth before it can become systemic. This highly aggressive physical containment strategy may be effective at eliminating small, newly-formed cell clusters that could otherwise develop into malignant tumors.

Growth Patterns and Tumor Development

The lobster’s unique physiology and life cycle, particularly its method of growth, also contribute a structural layer of resilience against tumor development. Lobsters grow by periodically shedding their hard outer shell, or exoskeleton, in a process known as molting. The old shell, which is completely cast off, includes the lining of the foregut, hindgut, and the gills.

Molting is a physically traumatic and energy-intensive event, but it may also serve as a natural cleansing mechanism. Any surface-level growths, parasites, or potentially cancerous lesions attached to the exoskeleton or its linings are physically shed and discarded with the old shell. This periodic removal of external and superficial internal tissue may interrupt the progression of early-stage tumors.

Furthermore, unlike vertebrates, lobsters possess an open circulatory system where hemolymph, their blood-like fluid, bathes the organs directly. This system, combined with their lower body temperature compared to mammals, may influence the rate at which malignant cells travel and proliferate. While a lower metabolism slows down biological processes, the physical interruption of the molt cycle remains a compelling structural explanation for the rarity of widespread cancer.